Deventer Sander van Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Deventer Sander van.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Deventer Sander van. Deventer Sander van is Director in ARGOS THERAPEUTICS INC ($ARGS) and Chief Scientific Officer in uniQure N.V. ($QURE) and Director in uniQure N.V. ($QURE) and EVP, Research & Product Dev. in uniQure N.V. ($QURE) and Director in HOOKIPA Pharma Inc. ($HOOK).

Latest Insider Trading Transactions of Deventer Sander van

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARGS, HOOK, QURE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 23 2020	HOOK	HOOKIPA Pharma Inc ...	van Deventer Sander	Director	Grant	A	0.00	2,485	0	2,485	0 to 2.5 K
Jun 19 2020	HOOK	HOOKIPA Pharma Inc ...	van Deventer Sander	Director	Option Exercise	A	11.45	9,600	109,920	9,600
Mar 02 2020	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Option Exercise	A	51.81	21,719	1,125,261	21,719
Mar 02 2020	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Grant	A	0.00	12,380	0	61,599	49.2 K to 61.6 K (+25.15 %)
Jan 31 2020	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Grant	A	0.00	6,092	0	49,219	43.1 K to 49.2 K (+14.13 %)
Jan 30 2020	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Sell	S	62.10	923	57,318	43,127	44.1 K to 43.1 K (-2.10 %)
Jan 30 2020	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Sell	S	61.27	1,304	79,896	44,050	45.4 K to 44.1 K (-2.88 %)
Jan 03 2020	HOOK	HOOKIPA Pharma Inc ...	van Deventer Sander	Director	Option Exercise	A	9.96	9,600	95,616	9,600
Sep 19 2019	QURE	uniQure N.V.	van Deventer Sander	EVP, Research & Pro ...	Grant	A	0.00	15,000	0	45,354	30.4 K to 45.4 K (+49.42 %)
Apr 24 2019	HOOK	HOOKIPA Pharma Inc ...	van Deventer Sander	Director	Option Exercise	A	14.00	19,200	268,800	19,200
Jan 30 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Sell	S	31.31	1,358	42,519	40,313	41.7 K to 40.3 K (-3.26 %)
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Option Exercise	A	31.71	18,325	581,086	18,325
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Grant	A	0.00	10,913	0	41,571	30.7 K to 41.6 K (+35.60 %)
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Grant	A	0.00	5,589	0	30,658	25.1 K to 30.7 K (+22.29 %)
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Option Exercise	A	31.71	18,325	581,086	18,325
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Grant	A	0.00	10,913	0	41,571	30.7 K to 41.6 K (+35.60 %)
Jan 29 2019	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Grant	A	0.00	5,589	0	30,658	25.1 K to 30.7 K (+22.29 %)
Jan 31 2018	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Sell	S	18.53	5,985	110,902	25,069	31.1 K to 25.1 K (-19.27 %)
Jan 30 2018	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Option Exercise	A	19.39	20,788	403,079	20,788
Jan 30 2018	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Grant	A	0.00	7,795	0	31,054	23.3 K to 31.1 K (+33.51 %)
Sep 22 2017	QURE	uniQure N.V.	van Deventer Sander	Chief Scientific Of ...	Option Exercise	A	8.49	150,000	1,273,500	150,000
Jan 31 2017	QURE	uniQure N.V.	van Deventer Sander	Director	Option Exercise	A	0.00	11,000	0	16,000
Jan 31 2017	QURE	uniQure N.V.	van Deventer Sander	Director	Option Exercise	A	5.37	11,000	59,070	11,000
Jan 20 2017	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	A	4.85	9,500	46,075	9,500
Oct 03 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Grant	A	0.00	2,263	0	5,057	2.8 K to 5.1 K (+80.99 %)
Aug 04 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	P	5.50	1,159,090	6,374,995	1,159,090
Aug 04 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	P	0.00	1,545,454	0	6,199,961	4.7 M to 6.2 M (+33.20 %)
Jul 05 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Grant	A	0.00	1,427	0	2,794	1.4 K to 2.8 K (+104.39 %)
Jul 01 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	P	5.35	991,964	5,307,007	991,964
Jul 01 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	P	0.00	1,322,618	0	4,654,507	3.3 M to 4.7 M (+39.70 %)
Jun 14 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	A	7.41	5,500	40,755	5,500
Apr 04 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Grant	A	0.00	1,367	0	1,367	0 to 1.4 K
Mar 16 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	P	5.35	661,309	3,538,003	661,309
Mar 16 2016	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	P	0.00	881,745	0	3,331,889	2.5 M to 3.3 M (+35.99 %)
Jun 19 2015	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	A	7.80	5,500	42,900	5,500
Feb 12 2014	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	C	0.00	1,428,888	0	0
Feb 12 2014	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Option Exercise	C	0.00	984,840	0	0
Feb 12 2014	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	P	8.00	36,416	291,328	2,450,144	2.4 M to 2.5 M (+1.51 %)
Feb 12 2014	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	C	0.00	1,428,888	0	2,413,728	984.8 K to 2.4 M (+145.09 %)
Feb 12 2014	ARGS	ARGOS THERAPEUTICS ...	van Deventer Sander	Director	Buy	C	0.00	984,840	0	984,840	0 to 984.8 K

Page: 1